Maryam I. Azeem
Research Subjects
Research Interests
Maryam I. Azeem has a total of 31 co-authors. Here are the top co-authors by number of shared publications:
- Kavita M. Dhodapkar
Emory University 9 Department of Pediatrics Atlanta, Georgia
3 shared publications - Madhav V. Dhodapkar
Fred Hutchinson Cancer Center, Seattle, Washington, United States
3 shared publications - Ajay K. Nooka
Winship Cancer Institute, Emory University, Atlanta, USA
2 shared publications - Alyssa Duffy
Winship Cancer Institute, Emory University, Atlanta, Georgia, USA
2 shared publications - Craig C. Hofmeister
Department of Hematology/Medical Oncology, Emory University, Atlanta, GA
2 shared publications - Jonathan L. Kaufman
Winship Cancer Institute, Emory University, Atlanta, GA
2 shared publications
Latest Publications
- Open Access
- 31 July 2025
- Published by American Society for Clinical Investigation in Journal of Clinical Investigation
- Vol. 135 (19)
Early CD4+ T cell proliferation and chronic T cell engagement impact myeloma outcomes following T cell engager therapy
- 31 July 2025
- Published by American Society for Clinical Investigation in Journal of Clinical Investigation
- Vol. 135 (19)
Open AccessEarly CD4+ T cell proliferation and chronic T cell engagement impact myeloma outcomes following T cell engager therapy
- Open Access
- 2 May 2024
- Published by American Society for Clinical Investigation in Journal of Clinical Investigation
- Vol. 134 (12)
Tregs protect against combination checkpoint blockade toxicity induced by Tph and B cell interactions
- 2 May 2024
- Published by American Society for Clinical Investigation in Journal of Clinical Investigation
- Vol. 134 (12)
Open AccessTregs protect against combination checkpoint blockade toxicity induced by Tph and B cell interactions
- Open Access
- 1 August 2023
- Published by American Society for Clinical Investigation in Journal of Clinical Investigation
- Vol. 133 (15)
Regulation of antigen-specific T cell infiltration and spatial architecture in multiple myeloma and premalignancy
Entry of antigen-specific T cells into human tumors is critical for immunotherapy, but the underlying mechanisms are poorly understood. Here, we combined high-dimensional spatial analyses with in vitro and in vivo modeling to study the mechanisms underlying immune infiltration in human multiple myeloma (MM) and its precursor monoclonal gammopathy of undetermined significance (MGUS). Clustered tumor growth was a feature of MM but not MGUS biopsies, and this growth pattern was reproduced in humanized mouse models. MM biopsies exhibited intralesional as well as spatial heterogeneity, with coexistence of T cell–rich and T cell–sparse regions and the presence of areas of T cell exclusion. In vitro studies demonstrated that T cell entry into MM clusters was regulated by agonistic signals and CD2-CD58 interactions. Upon adoptive transfer, antigen-specific T cells localized to the tumor site but required in situ DC–mediated antigen presentation for tumor entry. C-type lectin domain family 9 member A–positive (CLEC9A+) DCs appeared to mark portals of entry for gradients of T cell infiltration in MM biopsies, and their proximity to T cell factor 1–positive (TCF1+) T cells correlated with disease state and risk status. These data illustrate a role for tumor-associated DCs and in situ activation in promoting the infiltration of antigen-specific T cells in MM and provide insights into spatial alterations in tumor/immune cells with malignant evolution.
- 1 August 2023
- Published by American Society for Clinical Investigation in Journal of Clinical Investigation
- Vol. 133 (15)
Open AccessRegulation of antigen-specific T cell infiltration and spatial architecture in multiple myeloma and premalignancy
Entry of antigen-specific T cells into human tumors is critical for immunotherapy, but the underlying mechanisms are poorly understood. Here, we combined high-dimensional spatial analyses with in vitro and in vivo modeling to study the mechanisms underlying immune infiltration in human multiple myeloma (MM) and its precursor monoclonal gammopathy of undetermined significance (MGUS). Clustered tumor growth was a feature of MM but not MGUS biopsies, and this growth pattern was reproduced in humanized mouse models. MM biopsies exhibited intralesional as well as spatial heterogeneity, with coexistence of T cell–rich and T cell–sparse regions and the presence of areas of T cell exclusion. In vitro studies demonstrated that T cell entry into MM clusters was regulated by agonistic signals and CD2-CD58 interactions. Upon adoptive transfer, antigen-specific T cells localized to the tumor site but required in situ DC–mediated antigen presentation for tumor entry. C-type lectin domain family 9 member A–positive (CLEC9A+) DCs appeared to mark portals of entry for gradients of T cell infiltration in MM biopsies, and their proximity to T cell factor 1–positive (TCF1+) T cells correlated with disease state and risk status. These data illustrate a role for tumor-associated DCs and in situ activation in promoting the infiltration of antigen-specific T cells in MM and provide insights into spatial alterations in tumor/immune cells with malignant evolution.